Sutro Biopharma, Inc. (STRO)
19.70
-0.84
(-4.11%)
USD |
NASDAQ |
Mar 03, 16:00
19.30
-0.40
(-2.03%)
After-Hours: 20:00
Sutro Biopharma Research and Development Expense (TTM) : 200.81M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GT Biopharma, Inc. | -- |
| Rhythm Pharmaceuticals, Inc. | 166.89M |
| Crinetics Pharmaceuticals, Inc. | 328.17M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |